Dio Corp
Dio Corp is a South Korean company that provides medical equipment, supplies, and distribution services, primarily serving the healthcare sector.
Business. Dio Corp (039840.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, though specific details regarding its operating segments and geographic presence are not disclosed. Dio Corp is listed on the KOSDAQ exchange.
Analyst recommendations
2 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Dio Corp (039840.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, though specific details regarding its operating segments and geographic presence are not disclosed. Dio Corp is listed on the KOSDAQ exchange.
Dio Corp's capital structure is characterized by a debt-to-equity ratio of 0.42, indicating a relatively conservative leverage position compared to industry norms. The company holds 39.6 billion KRW in cash and equivalents, but its long-term debt of 80.9 billion KRW results in a net cash position of -41.3 billion KRW, raising liquidity concerns. The current ratio of 1.43 suggests the company can cover its short-term liabilities with its current assets, but the negative net cash position highlights a potential liquidity risk.
Profitability metrics for Dio Corp show a return on equity (ROE) of -0.71% and a return on assets (ROA) of -0.42%, both of which are negative and significantly below the industry median for medical equipment and supplies firms. The company reported a net loss of 1.36 billion KRW for the period, despite generating 164.08 billion KRW in revenue and 110.23 billion KRW in gross profit. These figures suggest operational inefficiencies or cost overruns that are eroding profitability.
Dio Corp's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segmental or geographic breakdown limits the ability to assess exposure to regional or product-specific risks.
The company's growth trajectory appears to be under pressure, with no specific revenue growth rates provided in the input data. However, the negative net income and declining ROE suggest a challenging operating environment. Analysts have set a mean price target of 23,500 KRW, implying a potential upside of 46.9% from the current market price of 16,000 KRW. This optimism is tempered by the company's current financial performance and the absence of clear growth drivers.
Risk factors for Dio Corp include its negative net cash position, which could limit its ability to fund operations or invest in growth without external financing. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative net cash position is a key flag. The company's free cash flow of 1.38 billion KRW is modest and may not be sufficient to support significant capital expenditures or debt reduction without additional financing.
Recent events, including analyst price targets and recommendations, suggest a cautiously optimistic outlook from the investment community. The mean recommendation of 1.50 (on a scale from 1 to 5) indicates a slight bias toward buying, with one strong-buy and one buy recommendation. However, the absence of recent filings or transcripts limits the ability to assess the company's strategic direction or operational updates.
- Dio Corp operates in the medical equipment and supplies industry with a conservative debt structure but a negative net cash position.
- The company's profitability is weak, with negative ROE and ROA, and a net loss despite strong gross profit.
- Revenue concentration in a single segment and lack of geographic diversification increase operational risk.
- Analysts are cautiously optimistic, with a mean price target of 23,500 KRW, but the company's financial performance remains a concern.
- Liquidity risk is moderate, but the negative net cash position could limit growth or operational flexibility.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 1 533,60 |
| Revenue | —no estimate | —no estimate | 200,2B KRW |
| Operating income | —no estimate | —no estimate | 27,2B KRW |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Dio Corp Market data — financials · 2026-05-26
- Dio Corp Market data — analyst estimates · 2026-05-26